Answer
Yes, ravulizumab is contraindicated in patients with unresolved Neisseria meningitidis infection at treatment initiation.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked